share_log

Alnylam Pharmaceuticals | 8-K: Alnylam Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Period Activity

SEC ·  Oct 31, 2024 20:16

Summary by Moomoo AI

Alnylam Pharmaceuticals, Inc. has announced its financial results for the quarter ended September 30, 2024. The company released this information on October 31, 2024, through a press release that has been furnished as an exhibit to their Current Report on Form 8-K.The announcement, made pursuant to regulatory requirements, provides insight into the company's operational and financial performance for the third quarter of 2024. While specific financial figures are not disclosed in this filing, the full details are available in the accompanying press release.This disclosure is not considered "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference in any filings under the Securities Act of 1933 or the Exchange Act, unless expressly specified.
Alnylam Pharmaceuticals, Inc. has announced its financial results for the quarter ended September 30, 2024. The company released this information on October 31, 2024, through a press release that has been furnished as an exhibit to their Current Report on Form 8-K.The announcement, made pursuant to regulatory requirements, provides insight into the company's operational and financial performance for the third quarter of 2024. While specific financial figures are not disclosed in this filing, the full details are available in the accompanying press release.This disclosure is not considered "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference in any filings under the Securities Act of 1933 or the Exchange Act, unless expressly specified.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more